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Saudi ArabiaAbstract Middle East respiratory syndrome is the acute respiratory syndrome caused by betacoro-
navirus MERS-CoV. The first case of this disease was reported from Saudi Arabia in 2012. This
virus is lethal and is a close relative of a severe acute respiratory syndrome (SARS), which is respon-
sible for more than 3000 deaths in 2002–2003. According to Ministry of Health, Saudi Arabia. The
number of new cases is 457 in 2015. Riyadh has the highest number of reports in comparison to the
other cities. According to this report, males are more susceptible than female, especially after the
age of 40. Because of the awareness and early diagnosis the incidence is falling gradually. The
pre-existence of another disease like cancer or diabetic etc. boosts the infection. MERS is a zoonotic
disease and human to human transmission is low. The MERS-CoV is a RNA virus with protein
envelope. On the outer surface, virus has spike like glycoprotein which is responsible for the attach-
ment and entrance inside host cells. There is no specific treatment for the MERS-CoV till now, but
drugs are in pipeline which bind with the spike glycoprotein and inhibit its entrance host cells.
MERS-CoV and SAR-CoV are from the same genus, so it was thought that the drugs which inhibit
the growth of SARS-CoV can also inhibit the growth of MERS-CoV but those drugs are not com-
pletely inhibiting virus activity. Until we don’t have proper structure and the treatment of
MERS-CoV, We should take precautions, especially the health care workers, Camel owners and
Pilgrims during Hajj and Umrah, because they are at a higher risk of getting infected.
 2016 The Authors. Production and hosting by Elsevier B.V. on behalf of King Saud University. This is
an open access article under theCCBY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Contents
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Figure 1 Total number of cases in different cities of Saudi
Arabia in 2015.1. Introduction
Middle East respiratory syndrome (MERS) is an acute respira-
tory syndrome, Caused by MERS coronavirus or MERS-CoV.
MERS is responsible for the death of more than 587 people all
over the world from 2012 to 2015 (MOH, 2015). First and the
highest number of cases are reported from Saudi Arabia (Zaki
et al., 2012). Now in 24 countries MERS cases are reported
(Bermingham et al., 2012), in which Middle East countries
are on the top. Human coronaviruses (HCoVs) belong to the
genera Alphacoronavirus and Betacoronavirus. Betacoron-
aviruses are further divided into four genetic clades, clade a
to clade d (Gorbalenya et al., 2004). MERS-CoV belongs to
Betacoronavirus clade c. The other virus of this family is
responsible for common cold except SARS, which is responsi-
ble for the death of more than 8400 cases and 800 deaths
(World Health Organization, 2014).
Since its discovery, the virus has been described by various
names like Human betacoronavirus 2c EMC, human betacoro-
navirus 2c England-Qatar, human betacoronavirus 2C Jordan-
N3, betacoronavirus England 1 and novel coronavirus
(NCoV) in different literatures (Corman et al., 2014).
To keep uniformity finally the virus has been described as
Middle East Respiratory Syndrome by Coronavirus Study
Group (CSG) as the first report was from Middle East country
Saudi (Corman et al., 2014).
The first report of MERS-CoV was from a hospital in
Jeddah in Saudi Arabia in September 2012, when Dr. Zaki
from Egypt isolated it from the throat of a patient, who died
because of severe respiratory and renal failure (Groot et al.,
2013). After that, the condition became alarming and more
than 1600 cases have been reported from all over the world.
MERS is a zoonotic disease and thought to be spread by
camels (Reusken et al., 2010). Human to human transmission
is low (Sharif-Yakan and Kanj, 2014).
2. Origin of MERS-CoV and source of transmission
The origin of MERS-CoV is still unknown but the phylogenic
studies show that the main source of this virus is the camel
(Azhar et al., 2014), which got infected by African bats in past.
Human to human transmission is limited in the case of MERS.
Although, According to the current reports the transmission
rate is decreasing but still this seems to be widely present in
dromedary camels in the Middle East countries, the current
report from Agriculture ministry of Saudi Arabia has con-
ducted a test on 112 camels and have found that 85% of the
animals carried a deadly MERS- CoV, transmission is
expected to continue for a long period of time in these regions
hence situation is not completely under control. Because ofPlease cite this article in press as: Faridi, U. Middle East respiratory syndrome corona
Sciences (2016), http://dx.doi.org/10.1016/j.sjbs.2016.09.020that reason people all over the world, especially in Middle East
countries like Saudi Arabia should be aware of MERS, its
causes, and symptoms (Zumlaa et al., 2015).
3. Symptoms and risk factors
The symptoms of MERS are not very specific Based on reports
so far, people with pre-existing medical conditions (also called
comorbidities) may be more likely to become infected with
MERS-CoV, or have a severe case. (Pre-existing diseases like
Diabetes, Cancer, Chronic lung, heart, and Kidney disease)
Individuals with weak Immunity are also easy victims.
4. Structure and its relation with infection
MERS-CoV is a single standard RNA virus with large protein
envelope, where the protein covering holds around 30 kb long
RNA. The outer surface of the envelope has a spike-like struc-
ture which is responsible for the infection. This spike-like
structure is the glycoprotein. It has main protease and
papain-like proteases which help in RNA binding synthesis
and translation.
The spike-like trimeric structure (S glycoprotein) on envel-
ope interacts host cells and helps the virus to enter into it.
Target cells have CD26 or dipeptidyl peptidase 4 (DDP4)
(Raj et al., 2013), which acts as a receptor of S glycoprotein.
The cells possessing this DDP4 (CD26) are present mainly in
respiratory airways (Wang et al., 2013). Different studiesvirus (MERS-CoV): Impact on Saudi Arabia, 2015. Saudi Journal of Biological
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Middle East respiratory syndrome coronavirus (MERS-CoV): Impact on Saudi Arabia, 2015 3confirmed S glycoprotein is very important for viral infection
and mutation in the spike coding genes causes impairment of
viral binding with host cells.5. Prevention is better than cure
There is no specific treatment for the MERS-CoV till date, It
was thought that the antiviral drugs which target main pro-
tease and papain-like protease of SARS-CoV can be effectivePlease cite this article in press as: Faridi, U. Middle East respiratory syndrome corona
Sciences (2016), http://dx.doi.org/10.1016/j.sjbs.2016.09.020for MERS also (because both the viruses are from same
beta-corona virus family) but those drugs are not 100% effec-
tive on MERS (Lei et al., 2014). Although MERS-CoV can be
inhibited by type I interferons in vitro but patients will not be
cured completely. Some drugs like ribavirin (plus IFNa2b)
(Omrani et al., 2014), cyclosporin A, and mycophenolic acid,
Chloroquine, chlorpromazine, loperamide, and lopinavir inhi-
bit MERS-CoV growth in vitro but their activity on the human
is yet to be established. However, they can be the future drugs
for MERS-CoV.virus (MERS-CoV): Impact on Saudi Arabia, 2015. Saudi Journal of Biological
4 U. Faridi‘‘Prevention is better than Cure” is the best proverb for
MERS until we have the specific treatment for MERS. Camel
owners, health workers, and pilgrims are easiest targets for
MERS-CoV so they should take extra precautions, like health
workers should wear protective gears like gloves and masks
while treating the patients, Camel owners should avoid direct
contact with camel’s eye, nasal fluid, and faeces. Good infec-
tious disease surveillance and control measures can prevent
the major outbreak of MERS during mass gathering activities
like Haj or Umrah.
6. Statistical analysis
A total number of new cases and deaths reported all over the
world are 1633 and 587 respectively because of this deadly
virus MERS-CoV. (W.H.O. report 16 January 2016). Out of
which 1280 cases are from Saudi Arabia alone, i.e. 78% of
cases are from Saudi Arabia (MOH, Saudi Arabia). Second
place is of the Republic of South Korea, where 175 cases were
reported till June 2015.
The Ministry of Health, Saudi Arabia has done a com-
mendable job to overcome this serious issue by spreading
awareness, proper diagnosis and treatment which clearly
shows the significant fall in a number of cases reported.
In 2015 the number of cases reported is 457 which is way
too low when compared to previous years. The highest number
of new cases were reported in Riyadh (294), Al-Ahsa was in
second place with 56 new cases. Followed by eastern region
(21), Jeddah (17), Qassim (17), Najran (15), Taif (11) and
Madinah (17). Other cities had only 18 cases out of 457
(Fig. 1). (MOH 27 December 2014 to 29 December 2015).
Riyadh is the most heavily populated city in Saudi Arabia
with a number of hospitals where patients from other areas
come for treatment, and it has a significant number of camel
markets. Because of this Riyadh is found to be the number
one city where the most number of MERS cases have been
reported.
The ratio of males over the female was high, 66% male and
34% of female were infected (Fig. 2). The number of males and
females was 299 and 153. (For 3 cases no data available). The
number of males with an age group of 40 and above were
77.5% of total infected males (Fig. 3). The patients below 20
were found to be only two (2 and 14 years respectively). In
females, the number was 69% for the age group 40 and above
(Fig. 4). (MOH 1st January 2015 to 31st December 2015).
(All the static data used in this article are obtained from the
sites of MOH, Saudi Arabia, and W.H.O., Google scholar and
is easily accessible.)
7. Conclusion
The incidences are getting reduced because of the awareness of
the disease but still we don’t have a particular drug or vaccine
against MERS-CoV. There is a great need for a new drug for
the treatment of this deadly virus and vaccine to prevent the
disease. Many research laboratories are working to understand
the disease completely and to discover the drug or vaccine for
MERS-CoV. So we can hope that in future MERS will be
treatable as common Cold.Please cite this article in press as: Faridi, U. Middle East respiratory syndrome corona
Sciences (2016), http://dx.doi.org/10.1016/j.sjbs.2016.09.020Acknowledgments
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